176 related articles for article (PubMed ID: 32206083)
1. The potential drug for treatment in pancreatic adenocarcinoma: a bioinformatical study based on distinct drug databases.
Liu H; Zhou Q; Wei W; Qi B; Zeng F; Bao N; Li Q; Guo F; Xia S
Chin Med; 2020; 15():26. PubMed ID: 32206083
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
3. IRF8 and its related molecules as potential diagnostic biomarkers or therapeutic candidates and immune cell infiltration characteristics in steroid-induced osteonecrosis of the femoral head.
Liang XZ; Liu XC; Li S; Wen MT; Chen YR; Luo D; Xu B; Li NH; Li G
J Orthop Surg Res; 2023 Jan; 18(1):27. PubMed ID: 36627660
[TBL] [Abstract][Full Text] [Related]
4. A network pharmacology-based investigation of emodin against pancreatic adenocarcinoma.
Shi X; Huang B; Zhu J; Yamaguchi T; Hu A; Tabuchi M; Watanabe D; Yoshikawa S; Mizushima S; Mizushima A; Xia S
Medicine (Baltimore); 2023 May; 102(20):e33521. PubMed ID: 37335741
[TBL] [Abstract][Full Text] [Related]
5. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
6. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel candidate biomarkers for pancreatic adenocarcinoma based on TCGA cohort.
Jie Y; Peng W; Li YY
Aging (Albany NY); 2021 Feb; 13(4):5698-5717. PubMed ID: 33591944
[TBL] [Abstract][Full Text] [Related]
8. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
Xing X; Xia Q; Gong B; Shen Z; Zhang Y
Front Genet; 2022; 13():855557. PubMed ID: 35368701
[No Abstract] [Full Text] [Related]
9. The bioinformatics analysis of quercetin in octagonal lotus for the screening of breast cancer MYC, CXCL10, CXCL11, and E2F1.
Ma Y; Peng Z; Pan R; Zhu Z; Meng X; Hu H; Qiao X; Huang X; Hou M
Int J Immunopathol Pharmacol; 2021; 35():20587384211040903. PubMed ID: 34693792
[TBL] [Abstract][Full Text] [Related]
10. The Regulatory Network of Gastric Cancer Pathogenesis and Its Potential Therapeutic Active Ingredients of Traditional Chinese Medicine Based on Bioinformatics, Molecular Docking, and Molecular Dynamics Simulation.
Yang P; Liu P; Li J
Evid Based Complement Alternat Med; 2022; 2022():5005498. PubMed ID: 36471693
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract][Full Text] [Related]
12. [Active components and action mechanism of Shenmai Injection in treatment of atrial fibrillation based on network pharmacology and molecular docking].
Wang YX; Liu P; Li T; Qin XH; Zheng QS
Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4511-4521. PubMed ID: 34581057
[TBL] [Abstract][Full Text] [Related]
13. A study on the role of Taxifolin in inducing apoptosis of pancreatic cancer cells: screening results using weighted gene co-expression network analysis.
Chen SJ; Ren LK; Fei XB; Liu P; Wang X; Zhu CH; Pan YZ
Aging (Albany NY); 2024 Feb; 16(3):2617-2637. PubMed ID: 38305809
[TBL] [Abstract][Full Text] [Related]
14. [Identification of traditional Chinese drugs containing active ingredients for treating myocardial infarction and analysis of their therapeutic mechanisms by network pharmacology and molecular docking].
Zhao S; Liu K; Duan J; Tao X; Li W; Bai Y; Wei P; Xi M; Yang H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):13-25. PubMed ID: 35249866
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms, immune cell infiltration, and potential drugs for prostate cancer.
Yan Y; Mao X; Zhang Q; Ye Y; Dai Y; Bao M; Zeng Y; Huang R; Mo Z
Cancer Biomark; 2021; 31(1):87-96. PubMed ID: 33780364
[TBL] [Abstract][Full Text] [Related]
16. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
Li JL; Hou W
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
[TBL] [Abstract][Full Text] [Related]
17. Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases.
Wen X; Shao Z; Chen S; Wang W; Wang Y; Jiang J; Ma Q; Zhang L
Front Genet; 2020; 11():610350. PubMed ID: 33584809
[No Abstract] [Full Text] [Related]
18. Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation.
Huang Q; Lin J; Huang S; Shen J
Front Pharmacol; 2021; 12():787816. PubMed ID: 34955857
[No Abstract] [Full Text] [Related]
19. Exploring the mechanism of action Xianlingubao Prescription in the treatment of osteoporosis by network pharmacology.
Zhu N; Hou J
Comput Biol Chem; 2020 Apr; 85():107240. PubMed ID: 32126522
[TBL] [Abstract][Full Text] [Related]
20. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
Xu Q; Zheng J; Su Z; Chen B; Gu S
BMC Gastroenterol; 2023 Nov; 23(1):397. PubMed ID: 37974070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
